240 related articles for article (PubMed ID: 29289814)
1. Safety and acceptability of human papillomavirus testing of self-collected specimens: A methodologic study of the impact of collection devices and HPV assays on sensitivity for cervical cancer and high-grade lesions.
Leinonen MK; Schee K; Jonassen CM; Lie AK; Nystrand CF; Rangberg A; Furre IE; Johansson MJ; Tropé A; Sjøborg KD; Castle PE; Nygård M
J Clin Virol; 2018; 99-100():22-30. PubMed ID: 29289814
[TBL] [Abstract][Full Text] [Related]
2. Urine collection in cervical cancer screening - analytical comparison of two HPV DNA assays.
Tranberg M; Jensen JS; Bech BH; Andersen B
BMC Infect Dis; 2020 Dec; 20(1):926. PubMed ID: 33276740
[TBL] [Abstract][Full Text] [Related]
3. HPV testing in first-void urine provides sensitivity for CIN2+ detection comparable with a smear taken by a clinician or a brush-based self-sample: cross-sectional data from a triage population.
Leeman A; Del Pino M; Molijn A; Rodriguez A; Torné A; de Koning M; Ordi J; van Kemenade F; Jenkins D; Quint W
BJOG; 2017 Aug; 124(9):1356-1363. PubMed ID: 28391609
[TBL] [Abstract][Full Text] [Related]
4. Comparison of urine, self-collected vaginal swab, and cervical swab samples for detecting human papillomavirus (HPV) with Roche Cobas HPV, Anyplex II HPV, and RealTime HR-S HPV assay.
Cho HW; Ouh YT; Hong JH; Min KJ; So KA; Kim TJ; Paik ES; Lee JW; Moon JH; Lee JK
J Virol Methods; 2019 Jul; 269():77-82. PubMed ID: 30998958
[TBL] [Abstract][Full Text] [Related]
5. Validation of a new HPV self-sampling device for cervical cancer screening: The Cervical and Self-Sample In Screening (CASSIS) study.
El-Zein M; Bouten S; Louvanto K; Gilbert L; Gotlieb W; Hemmings R; Behr MA; Franco EL;
Gynecol Oncol; 2018 Jun; 149(3):491-497. PubMed ID: 29678360
[TBL] [Abstract][Full Text] [Related]
6. Human Papillomavirus Genotype Detection and Cytology Using a New Self-Sampling Method.
Yabusaki H; Ono M; Shiina N; Shiina Y
Asian Pac J Cancer Prev; 2024 May; 25(5):1673-1679. PubMed ID: 38809639
[TBL] [Abstract][Full Text] [Related]
7. Human papillomavirus testing versus repeat cytology for triage of minor cytological cervical lesions.
Arbyn M; Roelens J; Simoens C; Buntinx F; Paraskevaidis E; Martin-Hirsch PP; Prendiville WJ
Cochrane Database Syst Rev; 2013 Mar; 2013(3):CD008054. PubMed ID: 23543559
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of self-collected vaginal specimens for the detection of high-risk human papillomavirus infection and the prediction of high-grade cervical intraepithelial lesions in a high-burden, low-resource setting.
Toliman PJ; Kaldor JM; Badman SG; Phillips S; Tan G; Brotherton JML; Saville M; Vallely AJ; Tabrizi SN
Clin Microbiol Infect; 2019 Apr; 25(4):496-503. PubMed ID: 29906593
[TBL] [Abstract][Full Text] [Related]
9. Clinical evaluation of high-risk HPV detection on self-samples using the indicating FTA-elute solid-carrier cartridge.
Geraets DT; van Baars R; Alonso I; Ordi J; Torné A; Melchers WJ; Meijer CJ; Quint WG
J Clin Virol; 2013 Jun; 57(2):125-9. PubMed ID: 23518442
[TBL] [Abstract][Full Text] [Related]
10. High-risk human papillomavirus messenger RNA testing in physician- and self-collected specimens for cervical lesion detection in high-risk women, Kenya.
Ting J; Mugo N; Kwatampora J; Hill C; Chitwa M; Patel S; Gakure H; Kimani J; Schoenbach VJ; Poole C; Smith JS
Sex Transm Dis; 2013 Jul; 40(7):584-9. PubMed ID: 23965776
[TBL] [Abstract][Full Text] [Related]
11. Accuracy and effectiveness of HPV mRNA testing in cervical cancer screening: a systematic review and meta-analysis.
Arbyn M; Simon M; de Sanjosé S; Clarke MA; Poljak M; Rezhake R; Berkhof J; Nyaga V; Gultekin M; Canfell K; Wentzensen N
Lancet Oncol; 2022 Jul; 23(7):950-960. PubMed ID: 35709810
[TBL] [Abstract][Full Text] [Related]
12. Brush-based self-sampling in combination with GP5+/6+-PCR-based hrHPV testing: high concordance with physician-taken cervical scrapes for HPV genotyping and detection of high-grade CIN.
Dijkstra MG; Heideman DA; van Kemenade FJ; Hogewoning KJ; Hesselink AT; Verkuijten MC; van Baal WM; Boer GM; Snijders PJ; Meijer CJ
J Clin Virol; 2012 Jun; 54(2):147-51. PubMed ID: 22445557
[TBL] [Abstract][Full Text] [Related]
13. Accuracy of self-collected vaginal dry swabs using the Xpert human papillomavirus assay.
Catarino R; Vassilakos P; Bilancioni A; Bougel S; Boukrid M; Meyer-Hamme U; Petignat P
PLoS One; 2017; 12(7):e0181905. PubMed ID: 28750015
[TBL] [Abstract][Full Text] [Related]
14. Performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older: a subanalysis of the ATHENA study.
Castle PE; Stoler MH; Wright TC; Sharma A; Wright TL; Behrens CM
Lancet Oncol; 2011 Sep; 12(9):880-90. PubMed ID: 21865084
[TBL] [Abstract][Full Text] [Related]
15. Test performance and acceptability of self- versus provider-collected swabs for high-risk HPV DNA testing in female-to-male trans masculine patients.
Reisner SL; Deutsch MB; Peitzmeier SM; White Hughto JM; Cavanaugh TP; Pardee DJ; McLean SA; Panther LA; Gelman M; Mimiaga MJ; Potter JE
PLoS One; 2018; 13(3):e0190172. PubMed ID: 29538411
[TBL] [Abstract][Full Text] [Related]
16. High-risk human papillomavirus detection in self-sampling compared to physician-taken smear in a responder population of the Dutch cervical screening: Results of the VERA study.
Ketelaars PJW; Bosgraaf RP; Siebers AG; Massuger LFAG; van der Linden JC; Wauters CAP; Rahamat-Langendoen JC; van den Brule AJC; IntHout J; Melchers WJG; Bekkers RLM
Prev Med; 2017 Aug; 101():96-101. PubMed ID: 28579497
[TBL] [Abstract][Full Text] [Related]
17. Concordance of Anyplex™ II HPV HR assays with reference HPV assays in cervical cancer screening: Systematic review.
Biazin H
J Virol Methods; 2022 Mar; 301():114435. PubMed ID: 34919974
[TBL] [Abstract][Full Text] [Related]
18. Experience with high-risk human papillomavirus testing on vaginal brush-based self-samples of non-attendees of the cervical screening program.
Gök M; van Kemenade FJ; Heideman DA; Berkhof J; Rozendaal L; Spruyt JW; Beliën JA; Babovic M; Snijders PJ; Meijer CJ
Int J Cancer; 2012 Mar; 130(5):1128-35. PubMed ID: 21484793
[TBL] [Abstract][Full Text] [Related]
19. VALHUDES: A protocol for validation of human papillomavirus assays and collection devices for HPV testing on self-samples and urine samples.
Arbyn M; Peeters E; Benoy I; Vanden Broeck D; Bogers J; De Sutter P; Donders G; Tjalma W; Weyers S; Cuschieri K; Poljak M; Bonde J; Cocuzza C; Zhao FH; Van Keer S; Vorsters A
J Clin Virol; 2018 Oct; 107():52-56. PubMed ID: 30195193
[TBL] [Abstract][Full Text] [Related]
20. Pooled analysis of a self-sampling HPV DNA Test as a cervical cancer primary screening method.
Zhao FH; Lewkowitz AK; Chen F; Lin MJ; Hu SY; Zhang X; Pan QJ; Ma JF; Niyazi M; Li CQ; Li SM; Smith JS; Belinson JL; Qiao YL; Castle PE
J Natl Cancer Inst; 2012 Feb; 104(3):178-88. PubMed ID: 22271765
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]